Loss of Gα13 in B-cells linked to increased lymphoma risk due to dietary glutamine

FHS
July 29, 2024
10:15 pm

Researchers find that the deletion of Gα13 in B-cells increases lymphoma risk by enhancing proliferation in gut-associated lymph nodes. Dietary glutamine significantly promotes these effects, highlighting a crucial link between diet and cancer.

ESC 2024: GLP-1RAs lower CV risk in meta-analysis of 32,883

Results have been presented at the European Society of Cardiology (ESC) Congress 2024 of a meta-analysis that studied the cardiovascular outcomes of glucagon-like peptide-1 receptor

September 2, 2024

What to make of UnitedHealth Group’s rebate move

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

January 22, 2025

FDA OKs Updated COVID Vaccines

The FDA approved and granted emergency use authorization for updated 2024-2025 mRNA COVID-19 vaccines from Moderna (Spikevax) and Pfizer-BioNTech (Comirnaty), the agency announced on Thursday.

August 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.